What is LOPJLB’s current signal on VTVT?

LOPJLB’s latest quantitative signal on vTv Therapeutics Inc. (VTVT) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is VTVT in?

vTv Therapeutics Inc. (VTVT) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Where is vTv Therapeutics Inc. based / listed?

vTv Therapeutics Inc. is based in US, listed on NASDAQ.

vTv Therapeutics Inc. (VTVT)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$30.08-3.00%Close

SELLRECOVERY · day 36

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $79M
Beta: 0.28
P/E (TTM): -273.00

Short % float: 11.34%
Days to cover: 5.0
SI change: -1.6%

1W: -5.56%
1M: -9.64%

vs SPY 1W: -7.11%
vs SPY 1M: -11.41%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule,…

Employees: 26
Headquarters: US
Founded: 2015
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 2.6M
Float: 54.0%

vtvtherapeutics.com ↗

Key executives

Paul J. Sekhri — Chief Executive Officer, President & Chairman of the Board

Michael Steven Tung — Executive Vice President & Chief Financial Officer

Barry Brown — Chief Accounting Officer

SEC filings

EDGAR · CIK 16414890 · VTVT

Analyst consensus

Buy

Bullish750.0%

Neutral750.0%

Bearish00.0%

L $42.00Avg $42.00H $42.00

Target$42.00+39.63%

Last$30.08

Key stats

Prediction markets

Company news